Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB

Autor: Tak, Won Young 1, Chuang, Wan-Lobg 2, Chen, Chi-Yi 3, Tseng, Kuo-Chih 4, Lim, Young-Suk 5, Lo, Gin-Ho 6, Heo, Jeong 7, Agarwal, Kaushik 8, Bussey, Louise 9, Teoh, Sui Lynn 10, Tria, A. 10, Brown, Anthony 11, Anderson, Katie 9, Vardeu, Antonella 9, O’Brien, Susanne 9, Kopycinski, Jakub 9, Kolenovska, Radka 9, Barnes, Ellie 11, 12, Evans, Thomas 9, ⁎
Zdroj: In Journal of Hepatology December 2024 81(6):949-959
Databáze: ScienceDirect
Externí odkaz: